Karol Kurpiejewski

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pseudomonas Aeruginosa

Molecular Docking

Structure Activity Relationship

Childhood Cancer

Top Venues

RNA (New York, N.Y.)

Pharmaceuticals (Basel, Switzerland)

European biophysics journal : EBJ

This page only lists publications with an associated author ORCID identifier.

Publications

Jingping Geng, Magdalena Chrabąszczewska, Karol Kurpiejewski, Anna Stankiewicz-Drogon, Marzena Jankowska-Anyszka, Edward Darzynkiewicz, Renata Grzela
Cap-related modifications of RNA regulate binding to IFIT proteins. RNA (New York, N.Y.) (2024)
Karol Kurpiejewski, Karolina Piecyk, Maciej Lukaszewicz, Karol Kamel, Kazimierz Chmurski, Sebastian Kmiecik, Marzena Jankowska-Anyszka
The Synergistic Effect of N2 and N7 Modifications on the Inhibitory Efficacy of mRNA Cap Analogues. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Karol Kurpiejewski, Karolina Piecyk, Maciej Lukaszewicz, Karol Kamel, Kazimierz Chmurski, Sebastian Kmiecik, Marzena Jankowska-Anyszka
The Synergistic Effect of N2 and N7 Modifications on the Inhibitory Efficacy of mRNA Cap Analogues. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Karol Kurpiejewski, Marzena Jankowska-Anyszka, Renata Grzela
N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA. European biophysics journal : EBJ (2023)
Renata Grzela, Karolina Piecyk, Anna Stankiewicz-Drogon, Paulina Pietrow, Maciej Lukaszewicz, Karol Kurpiejewski, Edward Darzynkiewicz, Marzena Jankowska-Anyszka
N2 modified dinucleotide cap analogues as a potent tool for mRNA engineering. RNA (New York, N.Y.) (2022)